Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)

CAPS Rating: 2 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

Recs

0
Player Avatar TerryHoodSr (49.09) Submitted: 12/27/2012 11:10:32 AM : Outperform Start Price: $21.32 LGND Score: -11.57

TP $27

Featured Broker Partners


Advertisement